analytical characterisation raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-10-25 and is reviewed periodically as new material appears.
Melanotan II holds no marketing authorisation from the Food and Drug Administration, the European Medicines Agency, the UK Medicines and Healthcare products Regulatory Agency or Australia's Therapeutic Goods Administration. Products sold under that name are treated as unapproved new drugs, and their sale or import is prohibited in several jurisdictions. Other countries classify the peptide as a prescription-only medicine or place it among controlled substances, so the legal position changes with the destination market. No pharmacopoeial monograph supplies an official specification, because the material is not a licensed pharmaceutical. Consequently, products offered online are not manufactured to a shared public standard.
The peer-reviewed record is dominated by small early-phase studies, case reports and pharmacovigilance summaries rather than large randomised trials. Papers typically examine tanning response, receptor selectivity or patterns of reported adverse events. Many note that participants obtained the peptide outside a clinical setting, which limits verification of composition and administered amount. Reported events vary widely, and causality is frequently unclear because the identity and purity of self-sourced material are unknown. Open questions include whether repeated melanocortin receptor stimulation produces cumulative effects, and how often label claims match actual content.
Identification in laboratories relies on reversed-phase liquid chromatography coupled with tandem mass spectrometry, with product-ion spectra compared against a certified reference standard. High-resolution mass spectrometry supplies accurate mass confirmation, and peptide mapping after enzymatic digestion separates melanotan II from closely related analogues. Quantitation of seized material is complicated by unknown counter-ions and residual trifluoroacetate left from purification. Immunoassays raised against alpha-melanocyte-stimulating hormone can cross-react, so chromatographic confirmation is normally required. Urinary detection windows are short, and reported limits of detection differ substantially between laboratories.
Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its structure substitutes a lactam bridge between side chains to increase stability relative to the native hormone. The compound is also known by the shorthand MT-II and by several non-proprietary synonyms used in research catalogues. It is not an approved therapeutic product in any major jurisdiction; material sold under this name is typically offered as a laboratory reagent rather than as a medicine.
Activity is attributed to agonism at melanocortin receptors, particularly MC1R and MC4R. Activation of MC1R on melanocytes increases melanin synthesis, which underlies the reported tanning effect. MC4R engagement in the central nervous system is linked to appetite suppression and to effects on sexual arousal reported in early clinical studies. Those studies were small and were not designed to establish efficacy or long-term safety. Receptor selectivity among the melanocortin subtypes is not absolute, which complicates attribution of any effect to a single pathway.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Unapproved in the US, EU and Australia | Sale and import restricted; no licensed product |
| Typical test matrices | Urine, serum, seized powder | Urinary detection window is short |
| Primary identification method | LC-MS/MS against a reference standard | High-resolution mass used for confirmation |
| Data sources in the literature | Small trials, case reports, pharmacovigilance | No registrational trial dataset exists |
| Common marketing names | Melanotan 2, MT-II, MT-2 | Label content may not match declared peptide |
Scientific discussion of Melanotan-2 spans pharmacology, dermatology, and public-health literature. Laboratory studies examine its receptor binding and cellular effects, while clinical reports describe outcomes observed after unregulated use. These two bodies of work differ in rigour and intent. Peer-reviewed trials of the compound as a medicine are limited, so much of the available information comes from case reports and surveillance data. Authors frequently note the gap between experimental findings and real-world use.
Reported observations after unregulated use include shifts in skin pigmentation and, in some accounts, unintended changes to moles and other lesions. Whether these outcomes are causally linked to the compound, and how often they occur, remain open questions because controlled data are scarce. The absence of standardised dosing and verified product purity complicates interpretation. Researchers have called for better surveillance and analytical characterisation of samples obtained outside regulated channels. Conclusions drawn from anecdotal evidence should be treated as provisional.
Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.
Melanotan II is a synthetic peptide analog modeled on alpha-melanocyte-stimulating hormone, a naturally occurring signaling peptide involved in pigmentation. Its structure is a cyclic heptapeptide containing two non-natural substitutions, norleucine at position four and D-phenylalanine at position seven. These modifications resist enzymatic breakdown and extend the molecule's activity relative to the native hormone. The compound binds melanocortin receptors and is studied mainly as a pharmacological tool rather than a therapeutic product. It has never received approval as a medicine in any major jurisdiction.
The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.
Regulatory treatment varies by jurisdiction and has changed over time. In several countries the peptide is handled as an unapproved prescription medicine, and import or sale for human use is restricted, while elsewhere it falls under poisons or controlled-substance schedules. Enforcement activity against online vendors has been reported in Australia, New Zealand, the United Kingdom and the United States. Scholarly writing discusses melanotan-2 chiefly as an experimental tool and as a case study in unregulated peptide supply, and its precise legal position in any given country should be checked against current national schedules.
Lyophilised melanotan-2 is comparatively robust when kept dry, cold and dark, and a desiccated powder stored at minus twenty degrees Celsius or below is generally expected to retain its chemical integrity for extended periods. In solution the peptide is far less stable, with degradation proceeding through oxidation of tryptophan and histidine residues, hydrolysis adjacent to the lactam bridge, and aggregation at higher concentrations. Repeated freeze-thaw cycling accelerates loss of the parent peak. Working aliquots are therefore prepared once, held cold, and used without letting the stock return to ambient temperature.
CH2=CHCH2Cl + NaOH → CH2=CHCH2OH + NaCl Allyl alcohol can also be made by the rearrangement of propylene oxide, a reaction that is catalyzed by potassium alum at high temperature. The advantage of this method relative to the allyl chloride route is that it does not generate salt. Also avoiding chloride-containing intermediates is the "acetoxylation" of propylene to allyl acetate:
=== Chemicals === E-cigarette components include a mouthpiece, a cartridge (liquid storage area), a heating element or atomizer, a microprocessor, a battery, and some of them have a LED light at the tip. They are disposable or reusable devices. Disposable ones are not rechargeable and typically cannot be refilled with a liquid. There is a diverse range of disposable and reusable devices, resulting in broad variations in their structure and their performance. Since many devices include interchangeable components, users have the ability to alter the nature of the inhaled vapor. For the majority of e-cigarettes, many aspects are similar to their traditional counterparts, such as giving nicotine to the user. The use of an e-cigarette simulates the action of smoking, with a vapor that somewhat resembles cigarette smoke. E-cigarettes do not involve tobacco combustion, and they do not produce vapor between puffs. They do not produce sidestream smoke or sidestream vapor. Vapor production basically entails preprocessing, vapor generation, and postprocessing. First, the e-cigarette is activated by pressing a button, or other devices switch on by an airflow sensor or other type of trigger sensor. Then, power is released to an LED, other sensors, and other parts of the device, and to a heating element or other kind of vapor generator. Subsequently, the e-liquid flows by capillary action to the heating element or other devices to the e-cigarette vapor generator. Second, the e-cigarette vapor processing entails vapor generation.
deoxyadenosine Abbreviated in shorthand with dA. One of the four standard deoxyribonucleosides used in DNA molecules, consisting of an adenine base with its N9 nitrogen bonded to the C1 carbon of a deoxyribose sugar. Adenine bonded to ribose forms an alternate compound known simply as adenosine, which is used in RNA.
Sources: en.wikipedia.org
Tropic hormones are hormones that have other endocrine glands as their target. Most tropic hormones are produced and secreted by the anterior pituitary. The hypothalamus secretes tropic hormones that target the anterior pituitary, and the thyroid gland secretes thyroxine, which targets the hypothalamus and therefore can be considered a tropic hormone. The term tropic is from Ancient Greek τροπικός (tropikós), in the sense "of or pertaining to a turn or change", meaning "causing a change, affecting"; this is the same origin as trope. This should not be confused with trophic, as in similar-sounding trophic hormone – the words and concepts are both unrelated. Tropic hormones are contrasted with non-tropic hormones, which directly stimulate target cells.
In those who are otherwise healthy, there is little evidence that supplements have any benefits with respect to cancer or heart disease. Vitamin A and E supplements not only provide no health benefits for generally healthy individuals, but they may increase mortality, though the two large studies that support this conclusion included smokers for whom it was already known that beta-carotene supplements can be harmful. A 2018 meta-analysis found no evidence that intake of vitamin D or calcium for community-dwelling elderly people reduced bone fractures. Europe has regulations that define limits of vitamin (and mineral) dosages for their safe use as dietary supplements. Most vitamins that are sold as dietary supplements are not supposed to exceed a maximum daily dosage referred to as the tolerable upper intake level (UL or Upper Limit). Vitamin products above these regulatory limits are not considered supplements and should be registered as prescription or non-prescription (over-the-counter drugs) due to their potential side effects. The European Union, United States and Japan establish ULs. Dietary supplements often contain vitamins, but may also include other ingredients, such as minerals, herbs, and botanicals. Scientific evidence supports the benefits of dietary supplements for persons with certain health conditions. In some cases, vitamin supplements may have unwanted effects, especially if taken before surgery, with other dietary supplements or medicines, or if the person taking them has certain health conditions.
== Ubiquitous function == This enzyme can catalyse the conversion of many alternative substrates, including alcohols such as retinol, which it converts to retinal. It also has an important role in the metabolism of nitric oxide, which is reactive and often found in tissue in the form of S-nitrosoglutathione (GSNO), its adduct with glutathione (GSH). The enzyme is a class III alcohol dehydrogenase (ADH) encoded by the ADH5 gene in humans and can act as a S-nitrosoglutathione reductase (GSNOR). It is a primordial ADH that is ubiquitously expressed in plant and animals alike. GSNOR reduces GSNO to the unstable intermediate, S-hydroxylaminoglutathione, which then rearranges to form glutathione sulfinamide, or in the presence of excess GSH, forms glutathione disulfide and hydroxylamine.
We were only supposed to carry four passengers ... We had six." According to Maluțan, it was 12:08 when they left for Snagov. After they arrived there, Ceaușescu took Maluțan into the presidential suite and ordered him to get two helicopters filled with soldiers for an armed guard, and a further Dauphin to come to Snagov. Maluțan's unit commander replied on the phone, "There has been a revolution ... You are on your own ... Good luck!" Maluțan then said to Ceaușescu that the second motor was now warmed up and they needed to leave soon but he could only take four people, not six. Mănescu and Bobu stayed behind. Ceaușescu ordered Maluțan to head for Titu. Near Titu, Maluțan says that he received the national flights denial and had to land to not get shot down by the army. He did so in a field next to the old road that led to Pitești. Maluțan then told his four passengers that he could do nothing more. The Securitate men ran to the roadside and began to flag down passing cars. Two cars stopped, one of them driven by a forestry official and one a red Dacia driven by a local doctor. However, the doctor was not happy about getting involved and, after a short time driving the Ceaușescus, faked engine trouble. A bicycle repairman was then flagged down and drove them in his car to Târgoviște. The repairman, Nicolae Petrișor, convinced them that they could hide in an agricultural technical institute on the edge of town. When they arrived, the director there guided the Ceaușescus into a room and then locked them in.
Sources: en.wikipedia.org
=== Tolerance, dependence and withdrawal === Abrupt or rapid discontinuation from etizolam, as with benzodiazepines, may result in the appearance of the benzodiazepine withdrawal syndrome, including rebound insomnia. Neuroleptic malignant syndrome, a rare event in benzodiazepine withdrawal, has been documented in a case of abrupt withdrawal from etizolam. This is particularly relevant given etizolam's short half-life relative to benzodiazepines such as diazepam resulting in a more rapid drug level decrease in blood plasma levels. In a study that compared the effectiveness of etizolam, alprazolam, and bromazepam for the treatment of generalized anxiety disorder, all three drugs retained their effectiveness over 2 weeks, but etizolam became more effective from 2 weeks to 4 weeks. Administering .5 mg etizolam twice daily did not induce cognitive deficits over 3 weeks when compared to placebo. When multiple doses of etizolam, or lorazepam, were administered to rat neurons, lorazepam caused downregulation of alpha-1 benzodiazepine binding sites (tolerance/dependence), while etizolam caused an increase in alpha-2 benzodiazepine binding sites (reverse tolerance to anti-anxiety effects). Tolerance to the anticonvulsant effects of lorazepam was observed, but no significant tolerance to the anticonvulsant effects of etizolam was observed. Etizolam therefore has a reduced liability to induce tolerance, and dependence, compared with classic benzodiazepines.
=== 4 September === One person was killed in an SAF drone strike on a market in Manawashi, South Darfur. The drone responsible was shot down by the RSF over Mershing, with RSF commanders claiming that it was a Baykar Bayraktar Akıncı drone.
== Mechanism == Understanding of the underlying mechanisms that cause electrotaxis to occur is limited. The diversity of biological cells and environmental conditions make it likely that there are many different mechanisms that allow for cells to migrate due to electric fields. Some studies have indicated that certain organisms move passively without any specific sensing mechanisms applied to alter active motility.
Because ovulation is triggered by a surge in estradiol levels at mid-cycle, estrogen exposure during elagolix therapy might be greater around this time in some women. In addition to its activity as a GnRH antagonist, elagolix is a weak to moderate inducer of CYP3A and an inhibitor of P-glycoprotein. As a result, elagolix may affect the metabolism and/or transport of other medications, and this may contribute to drug interactions with elagolix.
And thy Lord taught the Bee to build its cells in hills, on trees, and in (men's) habitations; Then to eat of all the produce (of the earth), and find with skill the spacious paths of its Lord: there issues from within their bodies a drink of varying colours, wherein is healing for men: verily in this is a Sign for those who give thought. In Hinduism, honey (Madhu) is one of the five elixirs of life (Panchamrita). In temples, honey is poured over the deities in a ritual called Madhu abhisheka. The Vedas and other ancient literature mention the use of honey as a great medicinal and health food. In Buddhism, honey plays an important role in the festival of Madhu Purnima, celebrated in India and Bangladesh. The day commemorates Buddha's making peace among his disciples by retreating into the wilderness. According to legend, while he was there a monkey brought him honey to eat. On Madhu Purnima, Buddhists remember this act by giving honey to monks. The monkey's gift is frequently depicted in Buddhist art. In Jainism, the consumption of honey is strictly prohibited. This dietary restriction is rooted in the religion's fundamental ethical principle of nonviolence (ahimsa). Traditional Jain theology classifies honey as one of the four absolute prohibitions (maha-vigai) because its commercial extraction and harvesting inevitably involve the violent disruption of hives and the death of bees. Furthermore, classical Jain biological texts assert that the dense, viscous nature of honey makes it a continuous breeding ground for microscopic lifeforms (nigoda).
Sources: en.wikipedia.org
Regulatory treatment varies by country. In the United States, the European Union and Australia it is an unapproved drug and its sale is restricted, while some other jurisdictions list it as prescription-only or controlled. The applicable rules depend on the country of import.
Reversed-phase LC-MS/MS is the usual approach for both identification and quantitation. High-resolution mass spectrometry and peptide mapping serve as confirmatory methods. Immunoassays are rarely used alone because of cross-reactivity.
Published testing of seized and purchased samples frequently reports discrepancies between declared and measured peptide content. Counter-ion content and residual solvents add further variation. Independent analysis is the only way to confirm composition.
No. No major regulatory agency has granted a marketing authorisation for melanotan II as a medicine. Products sold under this name are generally presented as laboratory reagents and are not subject to the batch-release testing applied to approved drugs.